Speech-Language Pathologists in Niles, OH Accepting Medicare
47 Speech-Language Pathologists found. Showing 41 - 47
 Alexis Mckenzie Mccowin, MA-CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606 Fax: 330-423-4555 |
Victoria Jude Villano Coblentz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606 Fax: 330-423-4555 |
Taylor Lynn Pagano Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800 |
Kathryn L. Fazekas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 960 Frederick St, Niles, OH 44446 Phone: 330-989-5091 |
Mrs. Rebecca Ann Sauline, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800 |
Marissa Christine Reed, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 918 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-1606 Fax: 330-505-2621 |
Sutherlyn Hollabaugh, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606 Fax: 330-423-4555 |
News Archive
Systematic review focuses on women's health associated with menopausal hormone therapy
Treatment with estrogen in menopause is both good and bad for women's health. The picture is complex and the scientific evidence sometimes scanty or only moderately solid, a study shows. University of Gothenburg researchers took part.
FDA grants 510(k) clearance to Carticept Medical's Navigator Delivery System
Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has received 510(k) clearance from the Food and Drug Administration to market its Navigator™ Delivery System (Navigator DS) in the United States.
Researchers find ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa
Researchers at Fox Chase Cancer Center in Philadelphia have identified a subset of ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa. The research was presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif.
Study analyzes attitudes and practices of general physicians in different vaccination scenarios
At population level, vaccines contribute to reducing mortality associated with infectious diseases such as measles, diphtheria, tetanus, hepatitis B or bacterial meningitis.
Newly developed technology can predict large volumes of unknown biochemical reactions
Fujitsu Laboratories Ltd., the Insight Centre for Data Analytics, a data analytics research institution based in Ireland, and Fujitsu (Ireland) Limited today announced the development of a technology that makes it possible to predict large volumes of unknown chemical reactions, about twice as many as the conventional procedure.
› Verified 4 days ago
Speech-Language Pathologists
Occupational Therapists
Physical Therapists
Optometrists
Chiropractors
Podiatrists